Page last updated: 2024-08-05 15:22:25
anti-asthmatic agent
Any compound that has anti-asthmatic effects.
ChEBI ID: 65023
Members (9)
Member | Definition | Class |
---|---|---|
betamethasone | betamethasone | |
davidigenin | A member of the class of dihydrochalcones that is dihydrochalcone substituted by hydroxy groups at positions 4, 2', and 4' respectively. | davidigenin |
ici 204,219 | zafirlukast | |
jte 013 | A semicarbazide derivative that is semicarbazide in which the amino group at position 2 is replaced by a [1,3-dimethyl-4-(propan-2-yl)-1H-pyrazolo[3,4-b]pyridin-6-yl]amino group and the amino group adjacent to the carbonyl is replaced by a (2,6-dichloropyridin-4-yl)amino group. It is a potent S1P2 antagonist (IC50 = 17.6 nM). | JTE-013 |
khellin | A furanochrome in which the basic tricyclic skeleton is substituted at positions 4 and 9 with methoxy groups and at position 7 with a methyl group. A major constituent of the plant Ammi visnaga it is a herbal folk medicine used for various illnesses, its main effect being as a vasodilator. | khellin |
matairesinol | A lignan that is gamma-butyrolactone in which the 3 and 4 positions are substituted by 4-hydroxy-3-methoxybenzyl groups (the 3R,4R-diastereomer). | (-)-matairesinol |
oridonin | An organic heteropentacyclic compound and ent-kaurane diterpenoid with formula C20H28O6 isolated from the leaves of the medicinal herb Rabdosia rubescens. | oridonin |
picrinine | A natural product with formula C20H22N2O3 that is the member of the akuammiline family of alkaloids, first isolated in 1965 from the leaves of Alstonia scholaris. | picrinine |
schizandrin b | An organic heterotetracyclic compound that is found in Fructus Schisandrae and Schisandra chinensis. | (+)-schisandrin B; Deoxygomisin A |
Research
Studies (10,817)
Timeframe | Studies, Drugs with This Role(%) | All Drugs % |
---|---|---|
pre-1990 | 3,828 (35.39) | 18.7374 |
1990's | 1,317 (12.18) | 18.2507 |
2000's | 2,090 (19.32) | 29.6817 |
2010's | 2,456 (22.71) | 24.3611 |
2020's | 1,126 (10.41) | 2.80 |
Study Types
Publication Type | Studies, Drugs with this Role (%) | All Drugs (%) |
---|---|---|
Trials | 1,501 (12.72%) | 5.53% |
Reviews | 941 (7.98%) | 6.00% |
Case Studies | 1,612 (13.66%) | 4.05% |
Observational | 50 (0.42%) | 0.25% |
Other | 7,695 (65.22%) | 84.16% |
Protein Targets (138)
Potency Measurements
Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
---|---|---|---|---|---|
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | Homo sapiens (human) | Potency | 21.1546 | 1 | 2 |
activating transcription factor 6 | Homo sapiens (human) | Potency | 10.6822 | 1 | 1 |
aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 0.0089 | 1 | 1 |
AR protein | Homo sapiens (human) | Potency | 2.5308 | 11 | 19 |
aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 13.3953 | 2 | 6 |
bromodomain adjacent to zinc finger domain 2B | Homo sapiens (human) | Potency | 50.1187 | 1 | 1 |
Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 8.4284 | 2 | 3 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | Homo sapiens (human) | Potency | 39.8107 | 1 | 1 |
Chain A, Beta-lactamase | Escherichia coli K-12 | Potency | 0.2512 | 1 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | Homo sapiens (human) | Potency | 0.8913 | 1 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | Homo sapiens (human) | Potency | 10.0000 | 1 | 1 |
cytochrome P450 2C19 precursor | Homo sapiens (human) | Potency | 5.0119 | 1 | 1 |
cytochrome P450 2C9, partial | Homo sapiens (human) | Potency | 12.3834 | 1 | 2 |
cytochrome P450 2D6 | Homo sapiens (human) | Potency | 21.5138 | 1 | 2 |
cytochrome P450 2D6 isoform 1 | Homo sapiens (human) | Potency | 10.0000 | 1 | 1 |
cytochrome P450 3A4 isoform 1 | Homo sapiens (human) | Potency | 7.5060 | 2 | 6 |
cytochrome P450 family 3 subfamily A polypeptide 4 | Homo sapiens (human) | Potency | 7.3954 | 2 | 4 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 0.0146 | 1 | 2 |
DNA polymerase beta | Homo sapiens (human) | Potency | 56.2341 | 1 | 1 |
DNA polymerase kappa isoform 1 | Homo sapiens (human) | Potency | 37.6858 | 1 | 1 |
estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 6.0393 | 6 | 9 |
estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 13.3332 | 1 | 1 |
estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 64.8601 | 2 | 2 |
euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 19.2293 | 1 | 3 |
EWS/FLI fusion protein | Homo sapiens (human) | Potency | 20.5627 | 4 | 4 |
farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 33.4889 | 2 | 2 |
G | Vesicular stomatitis virus | Potency | 12.3834 | 1 | 2 |
GABA theta subunit | Rattus norvegicus (Norway rat) | Potency | 7.5060 | 1 | 4 |
GALC protein | Homo sapiens (human) | Potency | 0.6310 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Potency | 7.5060 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Potency | 7.5060 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Potency | 7.5060 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 7.5060 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Potency | 7.5060 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Potency | 7.5060 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Potency | 7.5060 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 7.5060 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Potency | 7.5060 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Potency | 7.5060 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Potency | 7.5060 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Potency | 7.5060 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Potency | 7.5060 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Potency | 7.5060 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Potency | 7.5060 | 1 | 4 |
geminin | Homo sapiens (human) | Potency | 21.1360 | 1 | 1 |
GLI family zinc finger 3 | Homo sapiens (human) | Potency | 15.6058 | 2 | 5 |
glp-1 receptor, partial | Homo sapiens (human) | Potency | 11.2202 | 1 | 1 |
glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 4.6999 | 4 | 9 |
Glutamate receptor 2 | Rattus norvegicus (Norway rat) | Potency | 0.0841 | 1 | 1 |
GTP-binding nuclear protein Ran isoform 1 | Homo sapiens (human) | Potency | 20.5962 | 1 | 1 |
histone acetyltransferase KAT2A isoform 1 | Homo sapiens (human) | Potency | 9.9276 | 1 | 3 |
HLA class I histocompatibility antigen, B alpha chain | Homo sapiens (human) | Potency | 12.3834 | 1 | 2 |
hypoxia-inducible factor 1 alpha subunit | Homo sapiens (human) | Potency | 23.9145 | 1 | 1 |
IDH1 | Homo sapiens (human) | Potency | 3.6626 | 1 | 1 |
importin subunit beta-1 isoform 1 | Homo sapiens (human) | Potency | 20.5962 | 1 | 1 |
Inositol hexakisphosphate kinase 1 | Homo sapiens (human) | Potency | 12.3834 | 1 | 4 |
Interferon beta | Homo sapiens (human) | Potency | 12.3834 | 1 | 2 |
Luciferase | Photinus pyralis (common eastern firefly) | Potency | 18.1227 | 3 | 3 |
Microtubule-associated protein tau | Homo sapiens (human) | Potency | 25.1189 | 1 | 1 |
mitogen-activated protein kinase 1 | Homo sapiens (human) | Potency | 26.6514 | 2 | 2 |
neuropeptide S receptor isoform A | Homo sapiens (human) | Potency | 10.0000 | 1 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 29.0000 | 3 | 3 |
nuclear factor erythroid 2-related factor 2 isoform 2 | Homo sapiens (human) | Potency | 0.0108 | 2 | 2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | Homo sapiens (human) | Potency | 30.1065 | 1 | 1 |
nuclear receptor ROR-gamma isoform 1 | Mus musculus (house mouse) | Potency | 13.5346 | 2 | 2 |
nuclear receptor subfamily 1, group I, member 2 | Rattus norvegicus (Norway rat) | Potency | 14.1254 | 1 | 1 |
nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 12.8962 | 3 | 6 |
peripheral myelin protein 22 | Rattus norvegicus (Norway rat) | Potency | 5.4897 | 1 | 1 |
peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 8.0250 | 3 | 3 |
peroxisome proliferator-activated receptor delta | Homo sapiens (human) | Potency | 33.4889 | 1 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | Homo sapiens (human) | Potency | 35.4813 | 1 | 1 |
pregnane X nuclear receptor | Homo sapiens (human) | Potency | 22.3832 | 2 | 3 |
pregnane X receptor | Rattus norvegicus (Norway rat) | Potency | 17.7828 | 1 | 1 |
progesterone receptor | Homo sapiens (human) | Potency | 10.0073 | 3 | 4 |
retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 26.8325 | 1 | 1 |
snurportin-1 | Homo sapiens (human) | Potency | 20.5962 | 1 | 1 |
Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | Potency | 12.5893 | 1 | 1 |
survival motor neuron protein isoform d | Homo sapiens (human) | Potency | 1.2589 | 1 | 1 |
TDP1 protein | Homo sapiens (human) | Potency | 12.1267 | 2 | 3 |
thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 25.6204 | 2 | 2 |
thyroid hormone receptor beta isoform a | Homo sapiens (human) | Potency | 5.0119 | 1 | 1 |
USP1 protein, partial | Homo sapiens (human) | Potency | 37.6460 | 1 | 2 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 4.3386 | 2 | 2 |
vitamin D3 receptor isoform VDRA | Homo sapiens (human) | Potency | 36.2530 | 1 | 2 |
Voltage-dependent calcium channel gamma-2 subunit | Mus musculus (house mouse) | Potency | 0.0841 | 1 | 1 |
Inhibition Measurements
Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
---|---|---|---|---|---|
Adenosine receptor A3 | Homo sapiens (human) | IC50 | 1.3630 | 1 | 1 |
Adenosine receptor A3 | Homo sapiens (human) | Ki | 0.7700 | 1 | 1 |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 1.3630 | 1 | 1 |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.7700 | 1 | 1 |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 1.3630 | 1 | 1 |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.7700 | 1 | 1 |
ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | IC50 | 133.0000 | 1 | 2 |
Bifunctional epoxide hydrolase 2 | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
Bile salt export pump | Homo sapiens (human) | IC50 | 72.5500 | 3 | 4 |
Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | IC50 | 95.9000 | 1 | 2 |
Cysteinyl leukotriene receptor 1 | Cavia porcellus (domestic guinea pig) | IC50 | 0.0020 | 1 | 1 |
Cysteinyl leukotriene receptor 1 | Homo sapiens (human) | IC50 | 0.0039 | 5 | 5 |
Cysteinyl leukotriene receptor 1 | Cavia porcellus (domestic guinea pig) | Ki | 0.0003 | 2 | 2 |
Cysteinyl leukotriene receptor 1 | Homo sapiens (human) | Ki | 0.0006 | 2 | 2 |
Cysteinyl leukotriene receptor 2 | Homo sapiens (human) | IC50 | 22.1323 | 3 | 3 |
Cysteinyl leukotriene receptor 2 | Homo sapiens (human) | Ki | 0.0003 | 1 | 1 |
Cytochrome P450 1A1 | Homo sapiens (human) | IC50 | 4.0200 | 1 | 1 |
Cytochrome P450 1A1 | Homo sapiens (human) | Ki | 3.8000 | 1 | 1 |
Cytochrome P450 1A2 | Homo sapiens (human) | IC50 | 0.0400 | 1 | 1 |
Cytochrome P450 1A2 | Homo sapiens (human) | Ki | 0.0310 | 1 | 1 |
Cytochrome P450 1B1 | Homo sapiens (human) | IC50 | 34.6000 | 1 | 1 |
Cytochrome P450 2C19 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
Cytochrome P450 2C9 | Homo sapiens (human) | IC50 | 6.1288 | 2 | 2 |
Cytochrome P450 2C9 | Homo sapiens (human) | Ki | 2.5000 | 1 | 1 |
Cytochrome P450 2D6 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
Cytochrome P450 3A4 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
Cytosolic phospholipase A2 | Homo sapiens (human) | IC50 | 85.0000 | 1 | 1 |
Epidermal growth factor receptor | Homo sapiens (human) | IC50 | 5.7510 | 1 | 1 |
Estrogen receptor | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
Estrogen receptor beta | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
galanin receptor type 3 | Homo sapiens (human) | IC50 | 29.9000 | 1 | 1 |
Glucocorticoid receptor | Homo sapiens (human) | IC50 | 0.0077 | 1 | 1 |
Glucocorticoid receptor | Homo sapiens (human) | Ki | 0.0035 | 1 | 1 |
Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | IC50 | 0.0077 | 1 | 1 |
Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Ki | 0.0035 | 1 | 1 |
Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | IC50 | 0.0077 | 1 | 1 |
Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Ki | 0.0035 | 1 | 1 |
Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | IC50 | 0.0077 | 1 | 1 |
Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Ki | 0.0035 | 1 | 1 |
Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | IC50 | 0.0077 | 1 | 1 |
Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | Ki | 0.0035 | 1 | 1 |
Glycogen synthase kinase-3 beta | Homo sapiens (human) | IC50 | 0.0730 | 1 | 1 |
Mitogen-activated protein kinase 1 | Homo sapiens (human) | IC50 | 0.5380 | 1 | 1 |
Mitogen-activated protein kinase 14 | Homo sapiens (human) | IC50 | 0.3530 | 1 | 1 |
Mitogen-activated protein kinase 3 | Homo sapiens (human) | IC50 | 4.3760 | 1 | 1 |
Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | IC50 | 1,000.0000 | 1 | 1 |
Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | IC50 | 1.3000 | 1 | 1 |
Multidrug and toxin extrusion protein 2 | Homo sapiens (human) | IC50 | 7.6000 | 1 | 1 |
Multidrug resistance-associated protein 4 | Homo sapiens (human) | IC50 | 72.5500 | 1 | 2 |
NACHT, LRR and PYD domains-containing protein 3 | Mus musculus (house mouse) | IC50 | 0.8100 | 1 | 1 |
Sex hormone-binding globulin | Homo sapiens (human) | IC50 | 52.0000 | 1 | 1 |
Sodium/bile acid cotransporter | Homo sapiens (human) | IC50 | 4.6667 | 3 | 3 |
Solute carrier family 22 member 2 | Homo sapiens (human) | IC50 | 9.7000 | 1 | 1 |
Sphingosine 1-phosphate receptor 1 | Homo sapiens (human) | IC50 | 1.0000 | 2 | 2 |
Sphingosine 1-phosphate receptor 2 | Homo sapiens (human) | IC50 | 0.0401 | 6 | 6 |
Sphingosine 1-phosphate receptor 2 | Rattus norvegicus (Norway rat) | IC50 | 0.0200 | 1 | 1 |
Sphingosine 1-phosphate receptor 3 | Homo sapiens (human) | IC50 | 1.0000 | 2 | 2 |
Sphingosine 1-phosphate receptor 4 | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
Sphingosine 1-phosphate receptor 5 | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
Thromboxane-A synthase | Homo sapiens (human) | IC50 | 3.8100 | 1 | 1 |
Activation Measurements
Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
---|---|---|---|---|---|
Cysteinyl leukotriene receptor 1 | Homo sapiens (human) | Kd | 0.0000 | 1 | 1 |
Estrogen receptor | Rattus norvegicus (Norway rat) | EC50 | 50.0000 | 1 | 4 |
Estrogen receptor beta | Rattus norvegicus (Norway rat) | EC50 | 50.0000 | 1 | 4 |
Nuclear receptor subfamily 1 group I member 2 | Homo sapiens (human) | EC50 | 13.7275 | 4 | 4 |
Nuclear receptor subfamily 1 group I member 2 | Rattus norvegicus (Norway rat) | EC50 | 58.4000 | 1 | 1 |
ORF73 | Human gammaherpesvirus 8 | EC50 | 75.0000 | 1 | 1 |
Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | EC50 | 2.4400 | 1 | 1 |
Sex hormone-binding globulin | Homo sapiens (human) | Kd | 0.3090 | 1 | 1 |
Sphingosine 1-phosphate receptor 2 | Homo sapiens (human) | Kd | 1.9600 | 1 | 1 |
streptokinase A precursor | Streptococcus pyogenes M1 GAS | EC50 | 34.0167 | 2 | 3 |
Other Measurements
Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
---|---|---|---|---|---|
Sphingosine 1-phosphate receptor 2 | Homo sapiens (human) | Activity | 1.7500 | 1 | 1 |